After checking the expression of hypoxia-related proteins, we found that in the short-term treatment schedule, CKD-516 + IR and, more specifically, CKD-516 + IR (d1) treatment, decreased HIF-1α, Glut-1, and VEGF expression continuously from 24 h to 72 h. This evidence concerns the gene SLC2A1 and chronic kidney disease.